BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1559 related articles for article (PubMed ID: 29889418)

  • 1. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
    Sitkin SI; Tkachenko EI; Vakhitov TY
    Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
    Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gut microbiota: Description, role and pathophysiologic implications].
    Landman C; Quévrain E
    Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
    Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
    J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosa-associated microbiota dysbiosis in colitis associated cancer.
    Richard ML; Liguori G; Lamas B; Brandi G; da Costa G; Hoffmann TW; Pierluigi Di Simone M; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    Gut Microbes; 2018 Mar; 9(2):131-142. PubMed ID: 28914591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Human Gut Microbiota.
    Harmsen HJ; de Goffau MC
    Adv Exp Med Biol; 2016; 902():95-108. PubMed ID: 27161353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia.
    Lim JS; Lim MY; Choi Y; Ko G
    Mol Brain; 2017 Apr; 10(1):14. PubMed ID: 28427452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota and Alimentary Tract Injury.
    Chen Y; Wu G; Zhao Y
    Adv Exp Med Biol; 2020; 1238():11-22. PubMed ID: 32323177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does canine inflammatory bowel disease influence gut microbial profile and host metabolism?
    Xu J; Verbrugghe A; Lourenço M; Janssens GP; Liu DJ; Van de Wiele T; Eeckhaut V; Van Immerseel F; Van de Maele I; Niu Y; Bosch G; Junius G; Wuyts B; Hesta M
    BMC Vet Res; 2016 Jun; 12(1):114. PubMed ID: 27306031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Robinson AM; Gondalia SV; Karpe AV; Eri R; Beale DJ; Morrison PD; Palombo EA; Nurgali K
    Inflamm Bowel Dis; 2016 Dec; 22(12):2767-2787. PubMed ID: 27824648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis.
    Meisel M; Mayassi T; Fehlner-Peach H; Koval JC; O'Brien SL; Hinterleitner R; Lesko K; Kim S; Bouziat R; Chen L; Weber CR; Mazmanian SK; Jabri B; Antonopoulos DA
    ISME J; 2017 Jan; 11(1):15-30. PubMed ID: 27648810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
    Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
    J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation.
    Xu M; Cen M; Shen Y; Zhu Y; Cheng F; Tang L; Hu W; Dai N
    Dig Dis Sci; 2021 Feb; 66(2):568-576. PubMed ID: 32198567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrition, oxidative stress and intestinal dysbiosis: Influence of diet on gut microbiota in inflammatory bowel diseases.
    Tomasello G; Mazzola M; Leone A; Sinagra E; Zummo G; Farina F; Damiani P; Cappello F; Gerges Geagea A; Jurjus A; Bou Assi T; Messina M; Carini F
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):461-466. PubMed ID: 27812084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.